Our Blog

Sign Up for Our Newsletter

Stay up on the latest enFuse^® technology, partnerships, events, and news by signing up to receive the once-monthly Enable Injections Newsletter direct to your inbox.

Nigel-Sheail-photo

Enable Injections Enhances Board with Addition of Nigel Sheail

2022_1_20_EnableInjections_76039-WEB-Blue-2

Enable Injections Commits to Cincinnati Growth with Increased Jobs

feature-clinical-benefits

Thinking Clinically: Potential Benefits with the enFuse

ODD-feature-image-screenshot

Flexible Care – Enable Wearable Delivery

Enable Injections enFuse wearable delivery

enFuse Enables Flexibility for Pharma

Mehul-Desai-Enable-Injections-VP-Medical-Affairs

Mehul Desai Joins Enable Injections as VP, Medical Affairs

John-DeFord-Enable Injections-news-new-board-member

Enable Injections Enhances Board with Addition of John DeFord, Ph.D.

enFuse on body delivery

New Look, Same Mission – enFuse®

Enable Injections-enFuse-drug-delivery-innovation

Enable Injections Enhances Board with Addition of Three New Directors

subcutaneous wearable drug delivery technology

Large-Volume Wearable Drug Delivery Technology Is Clinically Proven

large-volume-enFuse-wearable-enable-injections

Large-Volume Subcutaneous Delivery Is Feasible

Large Volume Wearable Subcutaneous Delivery-Webinar

At-Home Drug Delivery of Large Molecule Medicines – The Future Is Now

Large-Volume Subcutaneous Delivery

Large-Volume Subcutaneous Delivery

Enable Injections-enFuse-drug-delivery-innovation

Sanofi announces partnership with Enable Injections, Inc. on subcutaneous delivery for Sarclisa®

Russell Pagano Joins Enable Injections as VP, Regulatory Affairs

Reducing treatment burden on nurses

Reducing the Treatment Burden on Nurses

Enable Injections-enFuse-drug-delivery-innovation

Enable Injections Announces $215 Million Financing

Enable-Injections-Superpower

What Is Enable Injections’ Superpower?

Improving Patient Access

Getting Care to Patients – A New Paradigm

Enable Injections Modular Scalable Manufacturing

Enable Manufacturing Excellence: State-of-the-Art Modular Scalable Manufacturing

Drug Delivery: What Do Patients Want?

Drug Delivery: What Do Patients and Providers Want?

Getting Care to Patients

Reimagining Patient Access to Treatment

Rethinking Drug Delivery

Rethinking Drug Delivery: Innovation to Improve Patient Access to Care

Holiday Celebration 2019, Fretboard

Enable Injections: Our Story and Team Culture

Getting Care to Patients

Delaying Therapy or Risking Exposure: A Decision No One Should Have to Make

The New Patient-Centricity

The New Patient-Centricity

Enable Injections enFuse

Letter from Mike Hooven, CEO, Enable Injections

Don-Kirkpatrick-v2d

Meet Enable’s New Chief Operating Officer, New Press on enFuse®

enFuse Vial Transfer System

New Utility Patent and enFuse® Vial Transfer System Technology

Forbes-article-Enable Injections SAP

enFuse® Featured in Forbes: This Pharma Startup Could Transform How Chronic Diseases Are Treated

Enable Injections enFuse 25-mL on-body infusor

Injection Devices: Wearables, Connectivity & Patient-Centric Designs Empower Self-Administration

OnDrugDelivery article Sept 2019 - Enable Injections

Key Challenges in Successful Wearable Drug Delivery and Patient Self-Administration

The Need for Advanced Delivery Reconstitution Systems

The Need for Advanced Delivery Reconstitution Systems

Scaling for Success: Why Enable Injections Is the Earliest-Stage Adopter of SAP

Scaling for Success: Why Enable Injections Is the Earliest-Stage Adopter of SAP

Combination Products: Success Is All about the Partnerships

Combination Products: Success Is All about the Partnerships

Enable enFuse and Autonomous Manufacturing

Autonomous Manufacturing for the Innovative enFuse On-Body Infusor

drug delivery device design and human factors

The Human Element in Drug Delivery Device Design

injection science blog post - enFuse On-Body Infusor - Enable Injections

Patient Tolerability with High-Viscosity, Large-Volume Subcutaneous Infusions

Advantages of Subcutaneous Administration: FDA Approvals by Route of Administration

Advantages of Subcutaneous Drug Delivery